Status:
RECRUITING
Respiratory Virus Infections in Acute Heart Failure
Lead Sponsor:
Minjae Yoon
Collaborating Sponsors:
Samsung Medical Center
Seoul St. Mary's Hospital
Conditions:
Acute Heart Failure Syndrome
Eligibility:
All Genders
19+ years
Brief Summary
Patients admitted to the cardiology department with acute heart failure who have a nasopharyngeal respiratory virus PCR test performed within 72 hours of admission will be enrolled in the study cohort...
Eligibility Criteria
Inclusion
- Adult aged 19 years or older admitted to the cardiology department with acute heart failure
- NT-proBNP \>300 pg/mL
- Clinician judgement of possible respiratory viral infection (fever \>38 degrees or cough, respiratory symptoms such as sputum or consolidation on x-ray or CRP \>5 mg/dL)
- Patients who have a nasopharyngeal swab for respiratory virus PCR test performed within 72 hours of admission for any of the 3 reasons
Exclusion
- Patients with a clear other cause of acute heart failure (ex. STEMI, bradycardia requiring a pacemaker, SBP \>200mmHg or DBP \>110mmHg, haemoglobin \<7g/dL)
- If the cause of pulmonary oedema is prominently attributed to exacerbation of CKD
- If there is a clear other source of infection that can explain the fever
Key Trial Info
Start Date :
April 7 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
360 Patients enrolled
Trial Details
Trial ID
NCT06967441
Start Date
April 7 2025
End Date
December 31 2028
Last Update
May 13 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620
2
Samsung medical center
Seoul, South Korea
3
Seoul ST. Mary's Hospital
Seoul, South Korea